A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Clinical trial NCT01937455 · UNKNOWN
Trial details
- NCT number
- NCT01937455
- Sponsor
- International AIDS Vaccine Initiative
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2018-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.